Manufacturing partnerships support high quality cell therapies
May 3, 2022 -- Chimeric Therapeutics, Ncardia, and Novartis are some of the companies that have decided to partner to make complex manufacturing processes more efficient for novel therapies, according to Cell and Gene Therapy Business Outlook, a sister publication of ScienceBoard. Read More
GVW and L7 discuss collaboration at Meeting on the Med
April 29, 2022 -- At the Cell & Gene Meeting on the Med in Barcelona, Spain, ScienceBoard.net spoke with Louis Hendriks, managing director at Global Value Web (GVW), and Vasu Rangadass, president and CEO at L7 Informatics, about the collaboration between the companies. Read More
Forge Biologics shares plans for growth at Meeting on the Med
April 29, 2022 -- Chief commercial officer John Maslowski and senior vice president of business development Magdalena Tyrpien of Forge Biologics spoke with ScienceBoard.net at the Cell & Gene Meeting on the Med in Barcelona, Spain, to discuss the return to live events and in-person collaboration, Forge's expansion, and how Forge's corporate culture and vision works for their growth. Read More
ProteoNic, NecstGen partner on viral vector manufacturing
April 28, 2022 -- ProteoNic and NecstGen are partnering to develop improved viral vector manufacturing for gene therapy applications, specifically using adeno-associated virus and lentivirus vectors. Read More
Mission Bio shares platform’s progress at Meeting on the Med
April 28, 2022 -- Mission Bio CEO Yan Zhang, PhD, and associate director of business development (cell and gene therapies) Nori Ueno spoke with ScienceBoard.net at the Cell & Gene Meeting on the Med in Barcelona, Spain, about the company's recent accomplishments with Tapestri, Mission Bio's single-cell platform for DNA analysis. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter